Your browser doesn't support javascript.
loading
TCR-based therapy for multiple myeloma and other B-cell malignancies targeting intracellular transcription factor BOB1.
Jahn, Lorenz; Hombrink, Pleun; Hagedoorn, Renate S; Kester, Michel G D; van der Steen, Dirk M; Rodriguez, Tania; Pentcheva-Hoang, Tsvetelina; de Ru, Arnoud H; Schoonakker, Marjolein P; Meeuwsen, Miranda H; Griffioen, Marieke; van Veelen, Peter A; Falkenburg, J H Frederik; Heemskerk, Mirjam H M.
Afiliación
  • Jahn L; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands.
  • Hombrink P; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands.
  • Hagedoorn RS; Department of Hematopoiesis, Sanquin Research, Amsterdam, The Netherlands.
  • Kester MG; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands.
  • van der Steen DM; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands.
  • Rodriguez T; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands.
  • Pentcheva-Hoang T; Research and Development, Bellicum Pharmaceuticals, Inc., Houston, TX.
  • de Ru AH; Research and Development, Bellicum Pharmaceuticals, Inc., Houston, TX.
  • Schoonakker MP; Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands.
  • Meeuwsen MH; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands.
  • Griffioen M; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands.
  • van Veelen PA; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands.
  • Falkenburg JH; Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands.
  • Heemskerk MH; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands.
Blood ; 129(10): 1284-1295, 2017 03 09.
Article en En | MEDLINE | ID: mdl-28053195

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfoma no Hodgkin / Receptores de Antígenos de Linfocitos T / Transactivadores / Inmunoterapia Adoptiva / Mieloma Múltiple Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Blood Año: 2017 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfoma no Hodgkin / Receptores de Antígenos de Linfocitos T / Transactivadores / Inmunoterapia Adoptiva / Mieloma Múltiple Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Blood Año: 2017 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Estados Unidos